Top 100 Contractors in NAICS 3254: Pharmaceutical and Medicine Manufacturing, FY2022

Parent companies by net contract obligations Oct 1, 2021 – Sep 30, 2022 Code page on GovTribe

The top 10 won 85% of FY2022 NAICS 3254 contract dollars

Ranking facts

Contract obligations
$47,265,822,172 Net of deobligations, by contracts coded NAICS 3254 or a code under it
Contractors
693 Parent companies with an obligation
Largest contractor
Pfizer Inc. $18 billion, 35.5% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 100 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1 $18,008,356,189
Rank history: #1 in FY2021, #2 in FY2023, not on the FY2024 list and #71 in FY2025; unchanged since FY2021.
2 $12,672,713,588
Rank history: #2 in FY2021, #1 in FY2023, #1 in FY2024 and #1 in FY2025; unchanged since FY2021.
3 $2,752,650,080
Rank history: #5 in FY2021 and not on the FY2023–FY2025 lists; up 2 since FY2021.
4 $2,155,922,482
Rank history: #3 in FY2021, #21 in FY2023 and not on the FY2024–FY2025 lists; down 1 since FY2021.
5 $1,940,524,299
Rank history: #6 in FY2021, #7 in FY2023, not on the FY2024 list and #30 in FY2025; up 1 since FY2021.
6
Ihealth Labs Inc.
$1,775,000,059
Rank history: not on the FY2021 list, #5 in FY2023 and not on the FY2024–FY2025 lists; new.
7 $1,636,317,290
Rank history: #9 in FY2021, #63 in FY2023, #14 in FY2024 and #20 in FY2025; up 2 since FY2021.
8 $994,126,910
Rank history: #7 in FY2021 and not on the FY2023–FY2025 lists; down 1 since FY2021.
9 $625,490,575
Rank history: #32 in FY2021, #13 in FY2023, #34 in FY2024 and not on the FY2025 list; up 23 since FY2021.
10 $605,483,222
Rank history: #15 in FY2021, #10 in FY2023 and not on the FY2024–FY2025 lists; up 5 since FY2021.
11 $603,086,708
Rank history: #55 in FY2021, #54 in FY2023, #49 in FY2024 and not on the FY2025 list; up 44 since FY2021.
12 $575,987,153
Rank history: #11 in FY2021 and not on the FY2023–FY2025 lists; down 1 since FY2021.
13 $401,153,911
Rank history: #17 in FY2021, #17 in FY2023 and not on the FY2024–FY2025 lists; up 4 since FY2021.
14 $359,462,727
Rank history: #8 in FY2021, #4 in FY2023, #2 in FY2024 and #2 in FY2025; down 6 since FY2021.
15 $293,125,000
Rank history: #13 in FY2021, #12 in FY2023, #7 in FY2024 and #5 in FY2025; down 2 since FY2021.
16 $139,936,193
Rank history: not on the FY2021 list, #48 in FY2023, not on the FY2024 list and #6 in FY2025; up 369 since FY2021.
17 $115,908,224
Rank history: #16 in FY2021, #11 in FY2023, #22 in FY2024 and #15 in FY2025; down 1 since FY2021.
18 $101,837,824
Rank history: #10 in FY2021, #8 in FY2023 and not on the FY2024–FY2025 lists; down 8 since FY2021.
19 $87,000,000
Rank history: not on the FY2021 list, #20 in FY2023, #11 in FY2024 and #33 in FY2025; new.
20 $80,087,668
Rank history: #39 in FY2021, #62 in FY2023, #88 in FY2024 and not on the FY2025 list; up 19 since FY2021.
21 $77,980,000
Rank history: #24 in FY2021, #15 in FY2023, #12 in FY2024 and #7 in FY2025; up 3 since FY2021.
22 $68,434,820
Rank history: #29 in FY2021, #22 in FY2023, #26 in FY2024 and #27 in FY2025; up 7 since FY2021.
23 $62,406,604
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
24 $60,345,096
Rank history: #20 in FY2021, #28 in FY2023, #19 in FY2024 and #23 in FY2025; down 4 since FY2021.
25 $59,026,988
Rank history: not on the FY2021 list, #34 in FY2023, #30 in FY2024 and #16 in FY2025; new.
26 $54,588,535
Rank history: not on the FY2021 list, #19 in FY2023 and not on the FY2024–FY2025 lists; new.
27 $51,999,850
Rank history: not on the FY2021 list, #33 in FY2023 and not on the FY2024–FY2025 lists; new.
28 $51,600,000
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
29 $48,332,504
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 141 since FY2021.
30
Amerisourcebergen Corporation Through Amerisourcebergen Drug Corp
$45,456,834
Rank history: not on the FY2021 list, #3 in FY2023, #3 in FY2024 and not on the FY2025 list; new.
31 $37,941,480
Rank history: #47 in FY2021, #44 in FY2023 and not on the FY2024–FY2025 lists; up 16 since FY2021.
32
Teva Pharmaceutical Industries Ltd. Through Teva Pharmaceuticals Usa, Inc.
$35,215,784
Rank history: #26 in FY2021, #25 in FY2023, #51 in FY2024 and not on the FY2025 list; down 6 since FY2021.
33 $31,129,442
Rank history: #30 in FY2021, #24 in FY2023, #21 in FY2024 and #17 in FY2025; down 3 since FY2021.
34 $30,173,950
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 454 since FY2021.
35 $30,135,185
Rank history: #23 in FY2021 and not on the FY2023–FY2025 lists; down 12 since FY2021.
36 $26,996,754
Rank history: #33 in FY2021, #72 in FY2023 and not on the FY2024–FY2025 lists; down 3 since FY2021.
37 $26,746,613
Rank history: #22 in FY2021, #47 in FY2023, #29 in FY2024 and not on the FY2025 list; down 15 since FY2021.
38 $25,521,675
Rank history: #34 in FY2021, #39 in FY2023, #32 in FY2024 and not on the FY2025 list; down 4 since FY2021.
39 $24,962,041
Rank history: #31 in FY2021, #32 in FY2023, #35 in FY2024 and not on the FY2025 list; down 8 since FY2021.
40 $23,750,030
Rank history: #14 in FY2021, #42 in FY2023, #75 in FY2024 and not on the FY2025 list; down 26 since FY2021.
41 $21,609,204
Rank history: #82 in FY2021, #23 in FY2023, #61 in FY2024 and not on the FY2025 list; up 41 since FY2021.
42 $20,996,275
Rank history: not on the FY2021 list, #38 in FY2023 and not on the FY2024–FY2025 lists; new.
43 $20,551,559
Rank history: #37 in FY2021, #40 in FY2023 and not on the FY2024–FY2025 lists; down 6 since FY2021.
44 $15,140,210
Rank history: #57 in FY2021, not on the FY2023–FY2024 lists and #56 in FY2025; up 13 since FY2021.
45 $13,562,904
Rank history: #27 in FY2021 and not on the FY2023–FY2025 lists; down 18 since FY2021.
46 $13,436,467
Rank history: not on the FY2021 list, #31 in FY2023, #23 in FY2024 and #19 in FY2025; up 126 since FY2021.
47 $13,316,956
Rank history: #42 in FY2021, #55 in FY2023, #41 in FY2024 and #83 in FY2025; down 5 since FY2021.
48 $12,619,832
Rank history: not on the FY2021 list, #60 in FY2023, #40 in FY2024 and not on the FY2025 list; new.
49 $12,457,855
Rank history: #41 in FY2021, #36 in FY2023 and not on the FY2024–FY2025 lists; down 8 since FY2021.
50 $12,318,053
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
51 $12,000,000
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
52 $10,821,029
Rank history: #77 in FY2021 and not on the FY2023–FY2025 lists; up 25 since FY2021.
53 $8,540,293
Rank history: not on the FY2021 list, #46 in FY2023, #44 in FY2024 and not on the FY2025 list; up 63 since FY2021.
54 $7,710,435
Rank history: #56 in FY2021, #45 in FY2023, #50 in FY2024 and #52 in FY2025; up 2 since FY2021.
55 $7,385,763
Rank history: #59 in FY2021, not on the FY2023 list, #33 in FY2024 and not on the FY2025 list; up 4 since FY2021.
56 $7,098,773
Rank history: #38 in FY2021, #41 in FY2023, #43 in FY2024 and not on the FY2025 list; down 18 since FY2021.
57 $6,830,000
Rank history: not on the FY2021 list, not on the FY2023 list, #25 in FY2024 and not on the FY2025 list; new.
58 $6,661,155
Rank history: #58 in FY2021, #35 in FY2023, #28 in FY2024 and not on the FY2025 list; unchanged since FY2021.
59 $6,532,347
Rank history: #71 in FY2021, #52 in FY2023, #62 in FY2024 and not on the FY2025 list; up 12 since FY2021.
60 $5,777,744
Rank history: #66 in FY2021, #56 in FY2023, #68 in FY2024 and #40 in FY2025; up 6 since FY2021.
61 $5,686,725
Rank history: #48 in FY2021, #82 in FY2023, not on the FY2024 list and #87 in FY2025; down 13 since FY2021.
62 $5,553,472
Rank history: #52 in FY2021, #53 in FY2023, #52 in FY2024 and #97 in FY2025; down 10 since FY2021.
63 $5,342,313
Rank history: #43 in FY2021 and not on the FY2023–FY2025 lists; down 20 since FY2021.
64 $4,971,968
Rank history: #49 in FY2021, #67 in FY2023, #71 in FY2024 and #63 in FY2025; down 15 since FY2021.
65 $4,800,000
Rank history: #74 in FY2021 and not on the FY2023–FY2025 lists; up 9 since FY2021.
66 $4,791,570
Rank history: #65 in FY2021, #49 in FY2023, #59 in FY2024 and #41 in FY2025; down 1 since FY2021.
67 $4,500,098
Rank history: #90 in FY2021, not on the FY2023 list, #54 in FY2024 and not on the FY2025 list; up 23 since FY2021.
68 $4,258,175
Rank history: #69 in FY2021, #66 in FY2023, #65 in FY2024 and not on the FY2025 list; up 1 since FY2021.
69 $4,143,392
Rank history: #72 in FY2021, #71 in FY2023, #96 in FY2024 and #72 in FY2025; up 3 since FY2021.
70 $3,530,618
Rank history: #99 in FY2021, #65 in FY2023, #72 in FY2024 and #64 in FY2025; up 29 since FY2021.
71 $3,367,815
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 103 since FY2021.
72 $3,308,074
Rank history: #98 in FY2021, #74 in FY2023 and not on the FY2024–FY2025 lists; up 26 since FY2021.
73 $3,134,479
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 118 since FY2021.
74 $3,037,000
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
75 $2,994,684
Rank history: not on the FY2021 list, not on the FY2023–FY2024 lists and #34 in FY2025; new.
76 $2,805,378
Rank history: #83 in FY2021, #92 in FY2023 and not on the FY2024–FY2025 lists; up 7 since FY2021.
77 $2,781,946
Rank history: #46 in FY2021 and not on the FY2023–FY2025 lists; down 31 since FY2021.
78 $2,662,192
Rank history: #88 in FY2021, #76 in FY2023, #74 in FY2024 and not on the FY2025 list; up 10 since FY2021.
79 $2,594,930
Rank history: #92 in FY2021, #80 in FY2023, #70 in FY2024 and #65 in FY2025; up 13 since FY2021.
80 $2,526,639
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
81 $2,465,591
Rank history: #75 in FY2021, #86 in FY2023, #82 in FY2024 and #89 in FY2025; down 6 since FY2021.
82 $2,363,102
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 50 since FY2021.
83 $2,352,087
Rank history: #78 in FY2021, #73 in FY2023 and not on the FY2024–FY2025 lists; down 5 since FY2021.
84 $2,329,992
Rank history: #62 in FY2021 and not on the FY2023–FY2025 lists; down 22 since FY2021.
85 $2,272,083
Rank history: not on the FY2021 list, #69 in FY2023, #56 in FY2024 and #48 in FY2025; up 27 since FY2021.
86 $2,215,596
Rank history: not on the FY2021 list, #85 in FY2023, #90 in FY2024 and #59 in FY2025; up 15 since FY2021.
87 $2,150,532
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 61 since FY2021.
88 $2,028,493
Rank history: not on the FY2021 list, #79 in FY2023, #69 in FY2024 and not on the FY2025 list; up 18 since FY2021.
89 $1,928,970
Rank history: #93 in FY2021, #88 in FY2023, #79 in FY2024 and #99 in FY2025; up 4 since FY2021.
90 $1,920,978
Rank history: not on the FY2021 list, #84 in FY2023 and not on the FY2024–FY2025 lists; up 51 since FY2021.
91 $1,895,644
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 76 since FY2021.
92 $1,852,594
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; up 22 since FY2021.
93 $1,837,809
Rank history: #25 in FY2021 and not on the FY2023–FY2025 lists; down 68 since FY2021.
94 $1,836,787
Rank history: #79 in FY2021, #58 in FY2023, #55 in FY2024 and #45 in FY2025; down 15 since FY2021.
95 $1,764,829
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
96 $1,764,488
Rank history: #67 in FY2021, #51 in FY2023, #58 in FY2024 and not on the FY2025 list; down 29 since FY2021.
97 $1,737,659
Rank history: #61 in FY2021 and not on the FY2023–FY2025 lists; down 36 since FY2021.
98 $1,673,389
Rank history: not on the FY2021 list, #16 in FY2023 and not on the FY2024–FY2025 lists; up 60 since FY2021.
99 $1,649,285
Rank history: #63 in FY2021, #89 in FY2023, not on the FY2024 list and #79 in FY2025; down 36 since FY2021.
100 $1,592,819
Rank history: not on the FY2021 list and not on the FY2023–FY2025 lists; new.
Show 75 more

100 of 693 contractors listed here. See the rest on GovTribe.

Rankings for the codes under NAICS 3254

Code Net obligations Largest contractor
32541 Pharmaceutical and Medicine Manufacturing $47,265,822,172 Pfizer Inc.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $50.7 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2022 ran Oct 1, 2021 – Sep 30, 2022. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2021. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2021 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 3254 contractors in FY2022?

1. Pfizer Inc. ($18B), 2. Mckesson Corporation ($12.7B), 3. ELI Lilly and Company ($2.75B), 4. Modernatx Inc. ($2.16B), 5. Abbott Laboratories ($1.94B), 6. Ihealth Labs Inc. ($1.78B), 7. Glaxosmithkline LLC ($1.64B), 8. Merck & Co. Inc. ($994M), 9. Roche Holding AG ($625M), 10. Quidel Corp ($605M).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work